Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Aris Water Solutions, Inc.Aris Water Solutions Reports 13% Revenue Growth, 34% Net Income Increase in Q3 2024
Kearny Financial Corp.Kearny Financial Corp. Reports Decline in Net Income, Net Interest Income Amid Increased Deposits and Cash Reserves
Enpro Inc.Enpro Inc. Reports Strong Q3 2024 Performance with Net Income Surging 138%
iWallet CorpiWallet Corp. Reports Net Loss, Reduced Operating Loss, and Increased Cash Position in Latest Quarter
GOODYEAR TIRE & RUBBER CO /OH/Goodyear Tire & Rubber Company Reports Mixed Q3 2024 Results, Net Loss Narrows
DuPont de Nemours, Inc.DuPont Reports 4% Revenue Growth in Q3 2024, Net Income Up 41%
NOVANTA INCNovanta Reports 10.3% Revenue Growth, $1.42 Billion in Total Assets as of September 27, 2024
Bank7 Corp.Bank7 Corp. Reports Significant Financial Improvements in Q3 2024, Net Income Up 50.5%
CRISPR Therapeutics AGCRISPR Therapeutics Reports Mixed Q3 Results, Revenue Growth and Expense Reductions Offset by Net Loss
uniQure N.V.uniQure Reports Revenue Growth, Improved Profitability, and Strategic Developments in Q3 and Nine Months 2024
Century Therapeutics, Inc.Century Therapeutics Reports Q3 2024 Financial Results, Collaboration Revenue Growth Amid Ongoing Losses
Beam Therapeutics Inc.Beam Therapeutics Reports Decline in Revenue and Net Loss, Despite Strategic Developments
TERADATA CORP /DE/Teradata Reports Mixed Q3 2024 Results with Slight Revenue Growth and Improved Profitability
ICHOR HOLDINGS, LTD.Ichor Holdings Reports 7.3% Revenue Growth, Improved Profitability in Q3 2024
Vishay Precision Group, Inc.Vishay Precision Group Reports Decline in Financial Performance for Q3 2024 and Nine Months Ended September 28, 2024
Inozyme Pharma, Inc.Inozyme Pharma Reports Financial Results, Advances Clinical Trials for Lead Product Candidate INZ-701
Nuvectis Pharma, Inc.Nuvectis Pharma Reports Improved Operating and Net Losses, Raises $8.1M Through ATM Offering
Amalgamated Financial Corp.Amalgamated Financial Corp. Reports Strong Q3 and Nine-Month Results, Driven by Asset Growth and Increased Interest Income
AquaBounty Technologies, Inc.AquaBounty Technologies Reports Significant Financial Decline, Net Loss Increases 240% in Latest Quarter
Portillo's Inc.Portillo's Reports 6.9% Revenue Growth, Net Income Increase in Q3 2024
Global Business Travel Group, Inc.Global Business Travel Group Reports 5% Revenue Growth, Net Loss in Q3 2024
Karyopharm Therapeutics Inc.Karyopharm Therapeutics Reports Mixed Q3 2024 Results, Ongoing Challenges in Profitability
Hillman Solutions Corp.Hillman Solutions Corp. Reports Mixed Financial Results for 13 and 39 Weeks Ended September 28, 2024
Bioventus Inc.Bioventus Reports 15% Revenue Growth, Improved Gross Profit and Operating Income in Q3 2024
Ally Financial Inc.Ally Financial Reports Mixed Q3 Results, Net Income Up 21% Amid Challenging Economic Environment